You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 58 No. 12, December 2001 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Contribution
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (25)
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in this journal
 Topic Collections
 •Hematology/ Hematologic Malignancies
 •Anemias
 •Hematology, Other
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Silent Infarcts in Children With Sickle Cell Anemia and Abnormal Cerebral Artery Velocity

Charles H. Pegelow, MD; Winfred Wang, MD; Suzanne Granger, MS; Lewis L. Hsu, MD; Elliott Vichinsky, MD; Franklin G. Moser, MD; Jacqueline Bello, MD; Robert A. Zimmerman, MD; Robert J. Adams, MD; Donald Brambilla, PhD; for the STOP Trial

Arch Neurol. 2001;58:2017-2021.

Background  A substantial minority of neurologically normal children with sickle cell disease have lesions consistent with cerebral infarction as seen on magnetic resonance imaging (MRI).

Objectives  To determine if transfusion therapy affects the rate at which silent infarcts develop and to evaluate the contribution of MRI of the brain to stroke prediction by transcranial Doppler (TCD) ultrasonography.

Study Design  Children with elevated TCD ultrasonographic velocity were randomized to receive long-term transfusion therapy or standard care. Magnetic resonance imaging of the brain was obtained at randomization, annually, and with clinical neurologic events. The risk for new silent lesions and/or stroke was compared for each treatment arm.

Results  Among the 37% of subjects with silent infarcts, those receiving standard care were significantly more likely to develop new silent lesions or stroke than were those who received transfusion therapy. For subjects receiving standard care, those with lesions at baseline were significantly more likely to develop stroke or new silent lesions than those whose MRI studies showed no abnormality.

Conclusions  Transfusion therapy lowers the risk for new silent infarct or stroke for children having both abnormal TCD ultrasonographic velocity and silent infarct. However, those with both abnormalities who are not provided transfusion therapy are at higher risk for developing a new silent infarct or stroke than are those whose initial MRI showed no abnormality. The finding of a silent infarct reinforces the need for TCD ultrasonographic screening and consideration of transfusion therapy if the abnormalities are seen. Similarly, elevated TCD ultrasonographic velocity warrants MRI of the brain because children with both abnormalities seem to be at increased risk for developing new silent infarct or stroke.


From the Department of Pediatrics, University of Miami, Miami, Fla (Dr Pegelow); St Jude Children's Research Hospital, Memphis, Tenn (Dr Wang); New England Research Institutes, Watertown, Mass (Ms Granger and Dr Brambilla); Emory University, Atlanta, Ga (Dr Hsu); Children's Hospital, Oakland, Calif (Dr Vichinsky); Cedars-Sinai Medical Center, Los Angeles, Calif (Dr Moser); Montefiore Medical Center, Bronx, NY (Dr Bello); Children's Hospital of Philadelphia, Philadelphia, Pa (Dr Zimmerman); and Medical College of Georgia, Augusta (Dr Adams).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLE

Archives of Neurology Reader's Choice: Continuing Medical Education
Arch Neurol. 2001;58(12):2078-2079.
FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Cerebrovascular reserve capacity is impaired in patients with sickle cell disease
Nur et al.
Blood 2009;114:3473-3478.
ABSTRACT | FULL TEXT  

Submandibular TCD approach detects post-bulb ICA stenosis in children with sickle cell anemia
Gorman et al.
Neurology 2009;73:362-365.
ABSTRACT | FULL TEXT  

Stroke Prevention Trial in Sickle Cell Anemia (STOP): extended follow-up and final results
Lee et al.
Blood 2006;108:847-852.
ABSTRACT | FULL TEXT  

Prevention and Management of Stroke in Sickle Cell Anemia
Platt
ASH Education Book 2006;2006:54-57.
ABSTRACT | FULL TEXT  

Genetics of Cerebrovascular Disorders
Meschia et al.
Mayo Clin Proc. 2005;80:122-132.
ABSTRACT  

Magnetic resonance angiography in children with sickle cell disease and abnormal transcranial Doppler ultrasonography findings enrolled in the STOP study
Abboud et al.
Blood 2004;103:2822-2826.
ABSTRACT | FULL TEXT  

Sickle Cell Disease
Buchanan et al.
ASH Education Book 2004;2004:35-47.
ABSTRACT | FULL TEXT  

Transcranial Doppler Ultrasonography and Neurocognitive Functioning in Children With Sickle Cell Disease
Kral et al.
Pediatrics 2003;112:324-331.
ABSTRACT | FULL TEXT  

Sickle Cell Disease: Continuous Arterial Spin-labeling Perfusion MR Imaging in Children
Oguz et al.
Radiology 2003;227:567-574.
ABSTRACT | FULL TEXT  

Reversible posterior leukoencephalopathy syndrome and silent cerebral infarcts are associated with severe acute chest syndrome in children with sickle cell disease
Henderson et al.
Blood 2003;101:415-419.
ABSTRACT | FULL TEXT  

Novel Therapeutic Approaches in Sickle Cell Disease
Walters et al.
ASH Education Book 2002;2002:10-34.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2001 American Medical Association. All Rights Reserved.